“There is no rational reason, other than greed, for
- Company “must substantially reduce the price of Ozempic in the US now,” Sanders says
- NOTE:
Ozempic, Wegovy Surge Puts Pressure on State Medicaid Plans
To contact the reporter on this story:
To contact the editors responsible for this story:
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.